Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Immunologically restricted patients exhibit a pronounced inflammation and inadequate response to hypoxia in fracture hematomas.

Hoff P, Gaber T, Schmidt-Bleek K, Sentürk U, Tran CL, Blankenstein K, Lütkecosmann S, Bredahl J, Schüler HJ, Simon P, Wassilew G, Unterhauser F, Burmester GR, Schmidmaier G, Perka C, Duda GN, Buttgereit F.

Immunol Res. 2011 Oct;51(1):116-22. doi: 10.1007/s12026-011-8235-9.

PMID:
21720875
2.

Human early fracture hematoma is characterized by inflammation and hypoxia.

Kolar P, Gaber T, Perka C, Duda GN, Buttgereit F.

Clin Orthop Relat Res. 2011 Nov;469(11):3118-26. doi: 10.1007/s11999-011-1865-3.

3.

A Pronounced Inflammatory Activity Characterizes the Early Fracture Healing Phase in Immunologically Restricted Patients.

Hoff P, Gaber T, Strehl C, Jakstadt M, Hoff H, Schmidt-Bleek K, Lang A, Röhner E, Huscher D, Matziolis G, Burmester GR, Schmidmaier G, Perka C, Duda GN, Buttgereit F.

Int J Mol Sci. 2017 Mar 8;18(3). pii: E583. doi: 10.3390/ijms18030583.

4.

Human immune cells' behavior and survival under bioenergetically restricted conditions in an in vitro fracture hematoma model.

Hoff P, Maschmeyer P, Gaber T, Schütze T, Raue T, Schmidt-Bleek K, Dziurla R, Schellmann S, Lohanatha FL, Röhner E, Ode A, Burmester GR, Duda GN, Perka C, Buttgereit F.

Cell Mol Immunol. 2013 Mar;10(2):151-8. doi: 10.1038/cmi.2012.56. Epub 2013 Feb 11.

5.

The immune microenvironment of human fracture/soft-tissue hematomas and its relationship to systemic immunity.

Hauser CJ, Zhou X, Joshi P, Cuchens MA, Kregor P, Devidas M, Kennedy RJ, Poole GV, Hughes JL.

J Trauma. 1997 May;42(5):895-903; discussion 903-4.

PMID:
9191672
6.

The early fracture hematoma and its potential role in fracture healing.

Kolar P, Schmidt-Bleek K, Schell H, Gaber T, Toben D, Schmidmaier G, Perka C, Buttgereit F, Duda GN.

Tissue Eng Part B Rev. 2010 Aug;16(4):427-34. doi: 10.1089/ten.TEB.2009.0687. Review.

PMID:
20196645
7.

Osteogenic activity of human fracture haematoma-derived progenitor cells is stimulated by low-intensity pulsed ultrasound in vitro.

Hasegawa T, Miwa M, Sakai Y, Niikura T, Kurosaka M, Komori T.

J Bone Joint Surg Br. 2009 Feb;91(2):264-70. doi: 10.1302/0301-620X.91B2.20827.

PMID:
19190066
8.

Elevated levels of macrophage colony-stimulating factor in human fracture healing.

Sarahrudi K, Mousavi M, Thomas A, Eipeldauer S, Vécsei V, Pietschmann P, Aharinejad S.

J Orthop Res. 2010 May;28(5):671-6. doi: 10.1002/jor.21048.

9.

Initial immune reaction and angiogenesis in bone healing.

Schmidt-Bleek K, Schell H, Lienau J, Schulz N, Hoff P, Pfaff M, Schmidt G, Martin C, Perka C, Buttgereit F, Volk HD, Duda G.

J Tissue Eng Regen Med. 2014 Feb;8(2):120-30. doi: 10.1002/term.1505. Epub 2012 Apr 11.

PMID:
22495762
10.

Trauma-induced inflammation and fracture healing.

Pape HC, Marcucio R, Humphrey C, Colnot C, Knobe M, Harvey EJ.

J Orthop Trauma. 2010 Sep;24(9):522-5. doi: 10.1097/BOT.0b013e3181ed1361. Review.

PMID:
20736786
11.

Bone morphogenic protein 2 induces Runx2 and osteopontin expression in human aortic valve interstitial cells: role of Smad1 and extracellular signal-regulated kinase 1/2.

Yang X, Meng X, Su X, Mauchley DC, Ao L, Cleveland JC Jr, Fullerton DA.

J Thorac Cardiovasc Surg. 2009 Oct;138(4):1008-15. doi: 10.1016/j.jtcvs.2009.06.024. Epub 2009 Aug 6.

12.

Osteogenic potential of hematoma in fracture healing--transplantation of hematoma under the periosteum of the parietal bone.

Mineo K, Mizuno K, Sumi M, Matsubara T, Hirohata K.

Kobe J Med Sci. 1988 Feb;34(1):31-47. No abstract available.

PMID:
3386191
13.

An in vitro study demonstrating that haematomas found at the site of human fractures contain progenitor cells with multilineage capacity.

Oe K, Miwa M, Sakai Y, Lee SY, Kuroda R, Kurosaka M.

J Bone Joint Surg Br. 2007 Jan;89(1):133-8.

14.

Cellular composition of the initial fracture hematoma compared to a muscle hematoma: a study in sheep.

Schmidt-Bleek K, Schell H, Kolar P, Pfaff M, Perka C, Buttgereit F, Duda G, Lienau J.

J Orthop Res. 2009 Sep;27(9):1147-51. doi: 10.1002/jor.20901.

15.

Immunolocalization of BMPs, BMP antagonists, receptors, and effectors during fracture repair.

Yu YY, Lieu S, Lu C, Miclau T, Marcucio RS, Colnot C.

Bone. 2010 Mar;46(3):841-51. doi: 10.1016/j.bone.2009.11.005. Epub 2009 Nov 11.

PMID:
19913648
16.

Bone regeneration and fracture healing. Experience with distraction osteogenesis model.

Richards M, Goulet JA, Weiss JA, Waanders NA, Schaffler MB, Goldstein SA.

Clin Orthop Relat Res. 1998 Oct;(355 Suppl):S191-204.

PMID:
9917639
17.

TNF-alpha mediates p38 MAP kinase activation and negatively regulates bone formation at the injured growth plate in rats.

Zhou FH, Foster BK, Zhou XF, Cowin AJ, Xian CJ.

J Bone Miner Res. 2006 Jul;21(7):1075-88.

18.

Enhancement of bone regeneration by gene delivery of BMP2/Runx2 bicistronic vector into adipose-derived stromal cells.

Lee SJ, Kang SW, Do HJ, Han I, Shin DA, Kim JH, Lee SH.

Biomaterials. 2010 Jul;31(21):5652-9. doi: 10.1016/j.biomaterials.2010.03.019. Epub 2010 Apr 21.

PMID:
20413153
19.

Production of interleukin-10 in human fracture soft-tissue hematomas.

Hauser CJ, Joshi P, Zhou X, Kregor P, Hardy KJ, Devidas M, Scott P, Hughes JL.

Shock. 1996 Jul;6(1):3-6.

PMID:
8828076
20.

Fates and osteogenic differentiation potential of human mesenchymal stem cells in immunocompromised mice.

Xia Z, Locklin RM, Triffitt JT.

Eur J Cell Biol. 2008 Jun;87(6):353-64. doi: 10.1016/j.ejcb.2008.02.013. Epub 2008 Apr 15.

PMID:
18417247

Supplemental Content

Support Center